MAPT and tauopathy: In the PS19 tauopathy model, 5-week resveratrol treatment in 6-month-old mice rescued cognitive deficits, attenuated tau pathology (phosphorylated tau and oligomers), suppressed neuroinflammation (glial activation and pro-inflammatory cytokines), and preserved synaptic markers in hippocampal region (Sun et al., 2019).